在状细胞病患者中优化单针红细胞交换
Lilora Kearney1, Regina Bosnick1, Haley Phillips2
1Department of Nursing, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Journal of clinical apheresis
|April 29, 2024
概括
状细胞疾病 (SCD) 患者经历单针红细胞交换 (SN-RCE) 脱血经历了血液溶解. 调整抗凝剂的流量和输入速率可以在化过程中解决这些溶血事件.
科学领域:
- 血液学 血液学 血液学
- 阿菲雷西斯技术的技术
- 状细胞疾病管理管理
背景情况:
- 状细胞疾病 (SCD) 的特点是高凝血状态,复杂化了非过程.
- 在SCD患者中,单针红细胞交换 (SN-RCE) 程序与溶血事件有关.
- 这些事件表现为变色的血,离心机中改变的接口,以及仪器报警,表明在血线中检测到红细胞 (RBC).
研究的目的:
- 在SCD患者的SN-RCE期间调查血液溶解事件的原因.
- 确定优化SN-RCE以防止血液溶解的策略.
- 为了评估修改的异位参数在预防血液溶解中的有效性.
主要方法:
- 追溯分析62个在15个月内进行的SN-RCE程序.
- 在SN-RCE和双针RCE程序之间比较警报频率.
- 修改了阿菲雷斯参数:增加了抗凝剂剂量 (输入/AC比从13到8) 和减少了输入速率.
主要成果:
- 在SN-RCE期间,4名患者发生了6次溶血事件,与血线中的红细胞相关的警报.
- 血液溶解源于非瑞斯仪器,而不是患者的外周血液.
- 与双针RCE (2.7%) 相比,SN-RCE (20.4%) 的血液溶解报警频率明显高,可能是由于红细胞凝聚.
- 调整后的抗凝剂和输入速率被很好地容忍,没有进一步的血液溶解.
结论:
- 在SCD患者的SN-RCE期间发生的溶血事件与仪器相关,可能是由红细胞凝结引起的.
- 优化输入/交流比率和输入速率可以有效地防止SN-RCE期间的血液溶解.
- 修改后的阿菲雷斯协议提高了SCD患者SN-RCE的安全性和效率.
相关概念视频
Bone Marrow Sampling and Transplants
326
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
326
Erythropoiesis
4.2K
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
4.2K
Blood Transfusion and Agglutination
10.8K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
10.8K


